Numata M - Search Results

1

Relationship between the -374T/A receptor of advanced glycation end products gene polymorphism and peritoneal solute transport status at the initiation of peritoneal dialysis.

Maruyama Y, Numata M, Nakayama M, Matsuo N, Nordfors L, Hosoya T, Lindholm B. Maruyama Y, et al. Among authors: numata m. Ther Apher Dial. 2007 Aug;11(4):301-5. doi: 10.1111/j.1744-9987.2007.00473.x. Ther Apher Dial. 2007. PMID: 17661837

2

Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate.

Numata M, Nakayama M, Nimura S, Kawakami M, Lindholm B, Kawaguchi Y. Numata M, et al. Perit Dial Int. 2003 Mar-Apr;23(2):116-22. Perit Dial Int. 2003. PMID: 12713076

3

Encapsulating peritoneal sclerosis is a separate entity: Con.

Nakayama M, Maruyama Y, Numata M. Nakayama M, et al. Among authors: numata m. Perit Dial Int. 2005 Feb;25 Suppl 3:S107-9. Perit Dial Int. 2005. PMID: 16048271

4

Possible pathologic involvement of receptor for advanced glycation end products (RAGE) for development of encapsulating peritoneal sclerosis in Japanese CAPD patients.

Numata M, Nakayama M, Hosoya T, Hoff CM, Holmes CJ, Schalling M, Nordfors L, Lindholm B. Numata M, et al. Clin Nephrol. 2004 Dec;62(6):455-60. doi: 10.5414/cnp62455. Clin Nephrol. 2004. PMID: 15630905

5

[Long-standing high-transport membrane as a risk factor for EPS development after PD withdrawal: an analysis based on changes in peritoneal function during and after CAPD withdrawal].

Nakayama M, Ikeda M, Katoh N, Hayakawa H, Numata M, Otsuka Y, Yamamoto R, Yamamoto H, Yokoyama K, Kubo H, Kawaguchi Y, Hosoya T. Nakayama M, et al. Among authors: numata m. Nihon Jinzo Gakkai Shi. 2002 May;44(4):396-401. Nihon Jinzo Gakkai Shi. 2002. PMID: 12073625 Japanese.

6

Hyper-vascular change and formation of advanced glycation endproducts in the peritoneum caused by methylglyoxal and the effect of an anti-oxidant, sodium sulfite.

Nakayama M, Sakai A, Numata M, Hosoya T. Nakayama M, et al. Among authors: numata m. Am J Nephrol. 2003 Nov-Dec;23(6):390-4. doi: 10.1159/000074065. Epub 2003 Oct 10. Am J Nephrol. 2003. PMID: 14551463

7

Suppression of N(epsilon)-(carboxymethyl)lysine generation by the antioxidant N-acetylcysteine.

Nakayama M, Izumi G, Nemoto Y, Shibata K, Hasegawa T, Numata M, Wang K, Kawaguchi Y, Hosoya T. Nakayama M, et al. Among authors: numata m. Perit Dial Int. 1999 May-Jun;19(3):207-10. Perit Dial Int. 1999. PMID: 10433156

8

Possible involvement of cross-linking advanced glycation endproducts in long-term CAPD peritoneal degeneration.

Nakayama M, Yoshimura K, Maruyama Y, Numata M, Hosoya T, Izumi G. Nakayama M, et al. Among authors: numata m. Nephrol Dial Transplant. 2004 Jun;19(6):1664-5. doi: 10.1093/ndt/gfh198. Nephrol Dial Transplant. 2004. PMID: 15150373 No abstract available.

9

[A study of association between lean body mass and serum insulin-like growth factor-1 in continuous ambulatory peritoneal dialysis patients].

Numata M, Yamamoto H, Kawaguchi Y, Osaka N, Nakayama M, Kubo H, Shigematsu T, Hosoya T. Numata M, et al. Nihon Jinzo Gakkai Shi. 1999 Jan;41(1):8-13. Nihon Jinzo Gakkai Shi. 1999. PMID: 10077982 Japanese.

10

Sodium sulfite and N-acetylcysteine: new additives to dialysate for inhibiting formation of glucose degradation products and advanced glycation end-products.

Sakai A, Nakayama M, Numata M, Takesawa S, Nakamoto M. Sakai A, et al. Among authors: numata m. Adv Perit Dial. 2001;17:66-70. Adv Perit Dial. 2001. PMID: 11510300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

578 results

Search Page

Filters